Company Filing History:
Years Active: 1996-1997
Title: The Innovations of Norman Spibey
Introduction
Norman Spibey is a notable inventor based in Glasgow, GB. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant viruses for veterinary applications. With a total of 2 patents, his work has implications for both animal health and vaccine development.
Latest Patents
One of Spibey's latest patents involves the recombinant canine adenovirus 2 (CAV-2). This patent describes a non-essential region in strains of live non-pathogenic immunogenic canine adenovirus. The invention details the insertion of genes from pathogenic carnivora viruses into this region, utilizing suitable expression control systems without compromising the stable reproducibility of the adenovirus vector. Additionally, it discusses recombinant canine adenoviruses modified to contain a gene coding for an antigen or immunogenic agent, in conjunction with an effective promoter for the gene. Another significant patent involves a fusion protein from feline leukaemia virus GP70, which is designed as a vaccine.
Career Highlights
Spibey is affiliated with the University of Glasgow, where he conducts his research and development work. His innovative approaches have positioned him as a key figure in the field of veterinary virology.
Collaborations
One of his notable collaborators is James Oswald Jarrett, with whom he has worked on various projects related to his patents.
Conclusion
Norman Spibey's contributions to biotechnology through his patents reflect his commitment to advancing veterinary medicine. His work continues to influence the development of effective vaccines for animals.